Evidence map›Paper›PMID 33649493›Full record

ArticleCommunications biology2021

Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics.

Chia-Feng Tsai, Pengfei Zhang, David Scholten, Kendall Martin, Yi-Ting Wang, Rui Zhao, William B Chrisler, Dhwani B Patel, Maowei Dou, Yuzhi Jia and 18 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. MR-SPJournal of proteome research · 2026
    Article
  9. Article
  10. Subcellular mass spectrometry reveals proteome remodeling in an asymmetrically dividing (frog) embryonic stem cell.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 6 institutions in 3 countries.

Chia-Feng Tsai *Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0002-6514-6911
Pengfei Zhang *Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
David Scholten *Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Kendall MartinBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Yi-Ting WangBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0001-7509-2016
Rui ZhaoEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.
William B ChrislerBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Dhwani B PatelDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Maowei DouEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.
Yuzhi JiaDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Carolina ReduzziDivision of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0003-0514-0152
Xia LiuDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Ronald J MooreBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0003-2806-2855
Kristin E Burnum-JohnsonBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0002-2722-4149
Miao-Hsia LinGraduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chuan-Chih HsuInstitute of Plant and Microbial Biology, Academia Sinica, Taipei, Taiwan.
Jon M JacobsBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0003-0557-7338
Jacob KaganCancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Sudhir SrivastavaCancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Karin D RodlandBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0001-7070-6541
H Steven WileyEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0003-0232-6867
Wei-Jun QianBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0002-5393-2827
Richard D SmithBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0002-2381-2349
Ying ZhuEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.
Massimo CristofanilliDivision of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Tao LiuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. tao.liu@pnnl.gov.ORCID 0000-0001-9529-6550
Huiping LiuDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. huiping.liu@northwestern.edu.ORCID 0000-0003-4822-7995
Tujin ShiBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. tujin.shi@pnnl.gov.ORCID 0000-0002-5592-3588
Pacific Northwest National Laboratory · USNorthwestern University · USNational Cancer Institute · USCentral South University · CNInstitute of Plant and Microbial Biology, Academia Sinica · TWNational Taiwan University · TW

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
CARCINOGENESIS TRAINING PROGRAMT32CA009560 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Kathleen Janee Green · 1986 to 2026
$8.4M
PNNL Proteome Characterization CenterU24CA210955 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI LIU, TAO, SMITH, RICHARD D · 2016 to 2020
$5.3M
Pathways and Regulators Driving Progressive Islet Cell Dysfunction in Type 1 DiabetesR01DK122160 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI ROHIT N. KULKARNI, CLAYTON E MATHEWS · 2019 to 2026
$3.7M
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of CancerU01CA227544 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI QIAN, WEI-JUN, SAURO, HERBERT M. · 2019 to 2023
$3.1M
Molecular mechanisms underlying circulating tumor cell aggregationR01CA245699 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LIU, HUIPING · 2020 to 2024
$2.0M
A streamlined platform for phosphoproteome mapping of human tissuesUH3CA256967 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI LIU, HUIPING, SHI, TUJIN · 2022 to 2023
$1.2M
A streamlined platform for phosphoproteome mapping of human tissuesUG3CA256967 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI LIU, HUIPING, SHI, TUJIN · 2020 to 2021
$800k
An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cellsR21CA223715 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SHI, TUJIN · 2018 to 2020
$691k
NCATS NIH HHS UL1 TR001422NCI NIH HHS R01 CA245699NCI NIH HHS R21 CA223715NCI NIH HHS T32 CA009560NCI NIH HHS U01 CA227544NCI NIH HHS U24 CA210955NCI NIH HHS UG3 CA256967NCI NIH HHS UH3 CA256967NIDDK NIH HHS R01 DK122160NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Large numbers of cells are generally required for quantitative global proteome profiling due to surface adsorption losses associated with sample processing. Such bulk measurement obscures important cell-to-cell variability (cell heterogeneity) and makes proteomic profiling impossible for rare cell populations (e.g., circulating tumor cells (CTCs)). Here we report a surfactant-assisted one-pot sample preparation coupled with mass spectrometry (MS) method termed SOP-MS for label-free global single-cell proteomics. SOP-MS capitalizes on the combination of a MS-compatible nonionic surfactant, n-Dodecyl-β-D-maltoside, and hydrophobic surface-based low-bind tubes or multi-well plates for 'all-in-one' one-pot sample preparation. This 'all-in-one' method including elimination of all sample transfer steps maximally reduces surface adsorption losses for effective processing of single cells, thus improving detection sensitivity for single-cell proteomics. This method allows convenient label-free quantification of hundreds of proteins from single human cells and ~1200 proteins from small tissue sections (close to ~20 cells). When applied to a patient CTC-derived xenograft (PCDX) model at the single-cell resolution, SOP-MS can reveal distinct protein signatures between primary tumor cells and early metastatic lung cells, which are related to the selection pressure of anti-tumor immunity during breast cancer metastasis. The approach paves the way for routine, precise, quantitative single-cell proteomics.

Indexed as

ProteomeProteomicsSingle-Cell AnalysisAnimalsBreast NeoplasmsChromatography, LiquidFemaleGlucosidesHumansLung NeoplasmsMCF-7 CellsMiceNeoplasm MicrometastasisNeoplasm ProteinsNeoplastic Cells, CirculatingSpectrometry, Mass, Electrospray Ionizationdodecyl maltosideGlucosidesNeoplasm ProteinsProteomeSurface-Active Agents

Identifiers

PMID33649493
PMCPMC7921383
OpenAlexW3134913640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.